Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Investors
Resources
Sample Case Studies
Clinical Research Repository
Customer Support
Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Careers
Investors
Resources
Case Studies
Clinical Research Repository
Customer Support
Legal
Privacy Policy
Disclaimer
Acceptable Use Policy
Contact Us
✕
No results
See all results
2017
June 5, 2019
June 5, 2019
AtCor Medical secures $0.8 million in new pharmaceutical contract
June 5, 2019
June 5, 2019
AtCor Medical signs new network health system agreement
June 5, 2019
June 5, 2019
Business update and strategic review
June 5, 2019
June 5, 2019
Half yearly reports and accounts
June 5, 2019
June 5, 2019
AtCor Medical signs local health system agreement
June 5, 2019
June 5, 2019
Study on central aortic waveform in heart failure
June 5, 2019
June 5, 2019
Tax refund
June 5, 2019
June 5, 2019
Central blood pressure and cognitive decline
June 5, 2019
June 5, 2019
Positive Novartis drug trial using SphygmoCor
Load more
Contact Us
No results
See all results
This website uses cookies to improve your experience. By using this website you agree to our
Data Protection Policy
.
Read more
Accept all
